Educational Activity

Page 16

Recently published articles about Educational Activity

JCP
Developments in Major Depressive Disorder Therapy
DELETE CME Institute Showcase

August 14, 2023

Among the greatest unmet needs in MDD is for effective pharmacotherapies for patients who do not respond to first- and second-line antidepressant medications. After decades of muted progress, alternatives...
Michael E. Thase
JCP
Evolving Research on Postpartum Depression Pathophysiology and Treatment
DELETE CME Institute Showcase

August 14, 2023

Research on neuroactive steroids reveals their role in perinatal depression, leading to development of novel therapeutics. These emerging treatments hold promise for faster onset and lasting effects.  
Kristina M. Deligiannidis, Rubiahna Vaughn
JCP
Emerging Therapies for Attention-Deficit/Hyperactivity Disorder
DELETE CME Institute Showcase

August 9, 2023

While patients with ADHD today still face numerous unmet needs, a number of newer pharmacologic agents and devices with potential advantages over traditional therapies have emerged and gained regulatory...
Jeffrey H. Newcorn
JCP
Emerging Perspectives in Addiction Psychiatry
DELETE CME Institute Showcase

August 9, 2023

FDA-approved medications and early intervention for people with substance use disorders should be encouraged as early as possible to optimize patient outcomes and life expectancy.
Ayana Jordan
JCP
Non-Dopaminergic Mechanisms for Schizophrenia Symptom Management
DELETE CME Institute Showcase

August 7, 2023

Next generation therapeutics that work well, are better tolerated, and lead to improved outcomes may offer a different treatment approach for patients with schizophrenia.
Leslie Citrome, Jonathan M. Meyer
JCP
Timely Diagnosis of Alzheimer Disease
Educational Activity

August 1, 2022

Early-stage diagnosis of Alzheimer disease leads to prompt treatment initiation and better patient QoL. Learn about new guidelines and technology advances and what’s on the horizon from authorities in...
Anna D. Burke, Danielle Goldfarb
JCP
Treatment of Early-Stage Alzheimer Disease
Educational Activity

August 1, 2022

Many new therapies for early-stage AD have made their way onto the scene that can delay onset of the disease and/or slow down progression. Find out the how, what,...
Anna D. Burke, Danielle Goldfarb
JCP
DELETE eView

October 26, 2021

Seizure clusters take a toll on patients’ emotional wellbeing, work, and quality of life. Learn from experts about new rescue treatments.
Kamil Detyniecki, Patricia Penovich
JCP
DELETE eReport

October 12, 2021

Can you recognize risk factors for tardive dyskinesia? Are you familiar with diagnostic criteria? Do you regularly assess patients for the condition? Are you knowledgeable about using new medications...
Christoph U. Correll, Leslie Citrome
JCP
DELETE eReport

July 13, 2021

Dr Krystal describes a new paradigm for managing insomnia in which clinicians can select interventions that best target the sleep problem of each patient. The result is an improved...
Andrew D. Krystal
JCP
DELETE eReport

July 6, 2021

Join Dr Goldberg as he reviews factors that impact the diagnosis of bipolar disorder and current treatments for bipolar depression in adults.
Joseph F. Goldberg
JCP
DELETE eReport

June 29, 2021

What are the evidence-based pharmacologic treatment approaches for pediatric patients with bipolar depression?
Robert L. Findling

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe